» Articles » PMID: 39202319

The Possible Associations Between Tauopathies and Atherosclerosis, Diabetes Mellitus, Dyslipidemias, Metabolic Syndrome and Niemann-Pick Disease

Overview
Specialty Radiology
Date 2024 Aug 29
PMID 39202319
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical evaluation and treatment of tauopathic syndromes remain a challenge. There is a growing interest in theories concerning their possible associations with metabolic diseases. The possible connection between those diseases might be linked with cerebrovascular dysfunction. The endothelial cell damage and impairment of the blood-brain barrier observed in atherosclerosis or diabetes may play a role in contributing to tauopathic syndrome development. Additionally, the inflammation evoked by pathological metabolic changes may also be involved in this process. Multiple cases indicate the coexistence of metabolic disorders and tauopathic syndromes. These findings suggest that modifying the evolution of metabolic and cerebrovascular diseases may impact the course of neurodegenerative diseases. Obtained data could indicate the possible benefits of introducing routine carotid artery sonography, revascularization operation or antihypertensive medications among patients at high risk for tauopathies. This review has identified this understudied area, which is currently associated with several diseases for which there is no treatment. Due to the pathomechanisms linking metabolic diseases and tauopathies, further investigation of this area of research, including cohort studies, is recommended and may provide new pharmacological perspectives for treatment.

Citing Articles

The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer's Disease: A Possible Target for the Disease Treatment.

Testa G, Giannelli S, Staurenghi E, Cecci R, Floro L, Gamba P Int J Mol Sci. 2025; 25(24.

PMID: 39769398 PMC: 11727734. DOI: 10.3390/ijms252413637.

References
1.
Yu J, Choi W, Lee H, Lee J . Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study. Medicine (Baltimore). 2019; 98(9):e14740. PMC: 6831265. DOI: 10.1097/MD.0000000000014740. View

2.
De Feo D, DAnzi A, Pestrichella V, Scicchitano P, Lafranceschina C, Caragnano V . TAVI in Patient Suffering from Niemann-Pick Disease (Acid Sphingomyelinase Deficiency) with Concomitant Situs Inversus and Dextrocardia. Cardiol Ther. 2023; 12(2):409-414. PMC: 10209358. DOI: 10.1007/s40119-023-00308-7. View

3.
Yarchoan M, Toledo J, Lee E, Arvanitakis Z, Kazi H, Han L . Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014; 128(5):679-89. PMC: 4304658. DOI: 10.1007/s00401-014-1328-5. View

4.
Dugger B, Malek-Ahmadi M, Monsell S, Kukull W, Woodruff B, Reiman E . A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases. Alzheimer Dis Assoc Disord. 2016; 30(3):223-9. PMC: 4940303. DOI: 10.1097/WAD.0000000000000138. View

5.
Lebovitz H . Thiazolidinediones: the Forgotten Diabetes Medications. Curr Diab Rep. 2019; 19(12):151. PMC: 6881429. DOI: 10.1007/s11892-019-1270-y. View